Will rich countries lift their waivers on patents for Covid-19 vaccines? | Inside Story

Poor nations are stepping up their fight for equal access to covid-19 vaccines.
They’re trying to convince rich nations to support their request for a waiver on patent rights.
They say acquiring vaccine knowledge could help them boost production of jabs.
President Joe Biden must now decide whether to change course and support the move.
The U.S. is one of several nations resisting the request at the world trade body, arguing it would discourage innovation.
Separately, the country’s about to get control of a patent – basically making it the owner of the technology at the heart of several vaccines.
Those drugs are built on this technology… so other producers will have to get licences from the U.S. to use it, once the patent is issued.
But will the U.S. use the opporunity to pressure drugmakers for more equal access?

Presenter: Kim Vinell

Thomas Pogge, Professor of Philosophy and Political Science at Yale University and Co-founder of Incentives for Global Health.
Samantha Vanderslott, Researcher at the Oxford Vaccine Group.
Max Lawson, Head of Inequality Policy at Oxfam International.

– Subscribe to our channel: http://aje.io/AJSubscribe
– Follow us on Twitter: https://twitter.com/AJEnglish
– Find us on Facebook: https://www.facebook.com/aljazeera
– Check our website: https://www.aljazeera.com/

#InsideStory #Vaccines #COVID-19 #Vaccination #Vaccine

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *